SB
SynBioBridge China Commercialization & Sourcing Hub
21 Years Industry Depth · Zhejiang Univ. Chemistry + Tsinghua MBA + APICS CPIM

Your Fractional GM, Technical KAM & Sourcing Partner in China.

We help global specialty functional ingredient, nutraceutical, and pharmaceutical excipient innovators enter China, upgrade underperforming distributors, penetrate Tier-1 key accounts, and source GMP-compliant raw materials directly from China's top manufacturers.

21+ Yrs
API, Nutraceutical & Functional Ingredients Leadership
0 to #1
Built NZ Bio-Protein Brand in China & Signed Top Distributor
-10% ~ -20%
Sourcing Cost Reduction via Disintermediation
58% → 300%
Margin Surge via Clean-Label Standard Redesign
WHO WE SERVE & PAIN POINTS WE SOLVE

Which China Challenge Is Holding You Back?

Whether you are a biotech startup, a mid-sized niche leader, or a multinational corporation, we solve your exact bottleneck.

01

Pre-Entry Innovators: 'Great Product, Unsure How to Enter China'

  • • Regulatory Maze: Confused by NHC 'New Food Ingredients', SAMR 'Blue Hat', or NMPA CDE drug/excipient filing timelines.
  • • Lost in Translation: Western clinical studies fail to convert Chinese B2B formulators when translated literally.
  • • Pricing & IP Fear: Worried about process leakage or mispricing in China's hyper-competitive market.
HIGHEST DEMAND
02

Partner Switchers: 'In China, But Frustrated With Current Distributor'

  • • 'Zombie Distributors': Giant traders carry 1,000+ SKUs and only push easy commodities, leaving your specialty ingredient neglected.
  • • Zero Technical Sales: Reps only forward quotes; projects die when R&D hits UHT stability, solubility, or taste hurdles.
  • • Black-Box Lock-In: Distributors hide end-customers, and you fear supply disruption if you switch partners.
03

Global Buyers: 'Sourcing Raw Materials & Syn-Bio Capacity in China'

  • • Middlemen Markup Fog: Overpaying 10%–20%+ to disguised 2nd/3rd-tier trading companies at expos.
  • • Quality Black Swans: Golden sample vs. inferior bulk cargo, catalyst residues, PAHs, or synthetic adulteration.
  • • Syn-Bio Scale-Up Mirage: Hard to verify which Chinese synthetic biology startups have real industrial tonnage capacity.
OUR CORE CAPABILITIES

End-to-End Commercialization & Supply Chain Services

SERVICE PILLAR 01

In-Depth Market Research & Feasibility Reports

De-risk your China entry before committing heavy capital.

• Product & Customer Fit Study Evaluate physicochemical stability, dosage forms, and exact demand across Chinese Pharma, Nutraceutical & F&B accounts.
• Chinese Legal & Regulatory Compliance Map NHC New Food Ingredient, SAMR Health Food, NMPA CDE excipient filing, or fast-track CBEC pathways.
• Localized Marketing & Pricing Strategy Translate clinical science into compliant Chinese marketing claims and build CIF-to-end-user pricing models.
• Partnership & Channel Architecture Recommend exclusive master distribution, regional split, or direct KAM models with a vetted shortlist of partners.
SERVICE PILLAR 02

China Brand Representation, KAM & Partner Matchmaking

Your Fractional China GM & Technical Sales Force.

• Direct Key Account Penetration (KAM) Build direct 'HQ R&D – Top Client' bridges with China's leading dairy, pharma, and supplement manufacturers.
• 6-Dimension Distributor Upgrade Use our proven 6-Dimension Scoring System to select, negotiate with, and manage top distributors (e.g., Zhongbai).
• Commercial Negotiation & Legal Guardrails Lead high-stakes commercial terms, bilingual contract drafting, IP protection, and non-circumvention clauses.
• Transparent Executive Pipeline Reporting Eliminate the 'China black box' with regular fluent English pipeline reviews and customer asset accumulation.
SERVICE PILLAR 03

Strategic Raw Material Sourcing & QA in China

Cut out middlemen and guarantee European-standard GMP quality.

• Disintermediation & Cost Reversal Analyze customs and production data to bypass traders and source directly from verified factories, saving 10%–20%.
• Synthetic Biology & Extract Capacity Locking Access China's top industrial-scale synthetic biology and natural extraction manufacturers for long-term supply.
• CPIM & European GMP Multi-Tier Audits Conduct unannounced factory audits, eliminate catalyst/solvent residues, and prevent synthetic adulteration.
• Supply Chain Finance & 100% On-Time Delivery Optimize working capital via innovative payment tools and dual-source backup inventory management.
5 TARGET INDUSTRIES

Tailored Go-To-Market Playbooks Across 5 Regulated Sectors

1. Pharmaceuticals

Specialty excipients & APIs. CDE registration & Type-A activation with top Chinese formulation makers.

2. Health Supplements

Navigate SAMR Blue-Hat rules, CBEC cross-border fast tracks, and top OEM/ODM formulator libraries.

3. Functional Foods

High-margin ingredients for eye health (carotenoids), immunity, anti-aging, gut health & sports nutrition.

4. Dairy & Nutrition

Deep access to China's top dairy giants for premium pediatric, maternal, and senior milk powder lines.

5. Food & Beverages

Co-solve UHT thermal stability, pH tolerance, solubility, and cost-in-use for mass beverage launches.

VERIFIED EXECUTIVE TRACK RECORD

Real Battles Won in China's Ingredient Market

CASE STUDY 01 · 0-TO-1 BRAND & CHANNEL BUILDING

New Zealand Bioactive Milk Protein (IDP®) China Launch

As China GM of Quantec (NZ), formulated the 5-year China sales strategy, persuaded HQ to localize marketing, and implemented a '6-Dimension Scoring System' to sign an exclusive master agency agreement with Zhongbai (China's largest food ingredient distributor). Built a direct 'HQ R&D – Top Client' bridge to penetrate top-tier Chinese dairy and health enterprises.

CASE STUDY 02 · FULL-CHAIN COMMERCIALIZATION & PHARMA

Active Eye-Health Carotenoid & Specialty Pharma Excipients

Independently integrated R&D, supply chain, and compliance resources to commercialize an 'active-configuration natural eye-health carotenoid', overcoming regulatory hurdles to win pilot orders from a major international key account for import substitution. Additionally, successfully introduced foreign specialty pharmaceutical excipients into China's leading API and formulation makers.

CASE STUDY 03 · SUPPLY CHAIN RESTRUCTURING & CLEAN LABEL

Cost Reversal (-20%) & 2nd-Gen Lutein Ester Margin Jump (300%)

Analyzed customs data to restructure sourcing for core botanical extracts (BB, BC, LUT), cutting out middlemen and reversing purchasing costs from 20% above competitors to 10%–20% below. Captured overseas demand for catalyst-residue-free 2nd-gen lutein esters, reshaping production standards and boosting product profit margin from 58% to 300%.

CASE STUDY 04 · SYNTHETIC BIOLOGY & GLOBAL API DOMINANCE

Tier-1 Syn-Bio Alliances & 150% International API Growth

As CIO at a Top-3 Chinese nutraceutical/pharma exporter (>RMB 2B revenue), forged strategic alliances with tier-1 Chinese synthetic biology manufacturers to lock in long-term R&D and capacity. Previously led international API sales at Lepu Medical (150% core product growth, >90% regional share) and managed Natural Products P&L at EPC Europe (>50% EU/JP market share).

JX

Jian Xue (薛俭)

Founder & Managing Partner

🎓 MBA, Tsinghua University (清华大学工商管理硕士)
🧪 B.S. Chemistry, Zhejiang University (浙江大学化学学士)
📦 APICS CPIM Certified (国际供应链管理师认证)

21 Years Bridging Scientific Chemistry with Global Executive P&L Leadership

Jian Xue brings a rare combination of deep chemical/pharmaceutical technical literacy and top-tier MBA commercial strategy. Over two decades, he has held senior executive roles including Deputy GM at Shanghai Daoyan Trading (a 30-year specialty ingredient distributor serving top dairy giants), Chief Innovation Officer (CIO) at Shanghai Xiangyuan Biotech (a Top-3 Chinese exporter with >RMB 2 Billion annual sales), China General Manager at New Zealand's Quantec Ltd., Senior Sales Director at Lepu Medical, and Head of Natural Products Business / Senior Manager Global Sourcing at EPC Natural Products Europe (16-year tenure).

Operating seamlessly in fluent Business English and Mandarin across Beijing, Shanghai, Hangzhou, and Guangzhou, Jian acts as a trusted, high-integrity extension of your executive team in China.

COMMERCIAL ENGAGEMENT & FEE STRUCTURE

Three Flexible, Results-Driven Engagement Models

MODEL 01 · FIXED PROJECT FEE

Market Feasibility Report (Per Report)

Charged per report based on regulatory complexity and research depth. Includes product-market fit, legal compliance roadmap, pricing architecture, and partner recommendations.

✓ Ideal for Pre-Entry Assessment (Credited toward long-term agency)
MODEL 02 · TRANSACTION COMMISSION

Sales & Sourcing Commission (Per Order)

Performance-based percentage commission on each completed domestic ingredient sale in China or raw material export order sourced from China. Aligned incentives with zero bloated overhead.

✓ Ideal for Active Commercialization & Direct Sourcing
MODEL 03 · BESPOKE PARTNERSHIP

Long-Term Strategic Retainer (Custom)

Tailored monthly/annual retainer + tiered success commission or Joint Venture (JV) equity model for clients requiring a dedicated Fractional China GM and full ongoing operational management.

✓ Ideal for Strategic Long-Term China Presence
GET IN TOUCH

Schedule a Confidential 30-Min China Strategy Call

Speak directly with Founder Jian Xue to assess your ingredient's regulatory feasibility, distributor performance, or sourcing cost-reduction potential in China.

Managing Partner: Jian Xue (薛俭)
Direct Phone / WeChat: +86 135-1100-8512
Hubs: Shanghai · Beijing · Hangzhou · Guangzhou